A Case Of Retroperitoneal Fibrosis As A Confusing Reason Of Positive FDG/PET
Role Of FDG/PET In Retroperitoneal Fibrosis
DOI:
https://doi.org/10.70284/njirm.v7i2.1375Keywords:
Retroperitoneal fibrosis, Fluorodeoxyglucose positron emission tomography, high erythrocyte sedimentatiton rateAbstract
Retroperitoneal fibrosis is a rare disease and characterized by the presence of fibrous and inflammatory
retroperitoneal tissue. Fluorine-18-fluorodeoxyglucose positron emission tomography (FDG/PET)is a beneficial
methods for inflammatory dieseases. We presented here a case of 40 year old woman with idiopathic retroperitoenal
fibrosis which detected high SUVmax level (21.4) on FDG/PET and had high erythrocyte sedimentatiton rate
(140mm/h). If high SUVmax is detected, histologic confirmation is necessary to exclude malignancies [Arslan E NJIRM
2016; 7(2):123-125]
References
1. Treglia G, Mattoli MV, Leccisotti L, Ferraccioli G,
Giordano A. Usefulness of whole-body fluorine-18-
fluorodeoxyglucose positron emission tomography
in patients with large-vessel vasculitis: a systematic
review. Clin Rheumatol. 2011;30:1265-75.
2. Tahara N, Imaizumi T, Virmani R, Narula
J.Clinicalfeasibilityofmolecular
imagingofplaqueinflammation in atherosclerosis. J
Nucl Med. 2009;50:331-4.
3. Nakajo M, Jinnouchi S, Tanabe H, Tateno R, Nakajo
M. 18F-fluorodeoxyglucose positron emission
tomography features of idiopathic retroperitoneal
fibrosis. J Comput Assist Tomogr. 2007;31:539-43.
4. van Bommel EF, Jansen I, Hendriksz TR, Aarnoudse
AL. Idiopathic retroperitonealfibrosis: prospective
evaluation of incidence and clinicoradiologic
presentation.Medicine (Baltimore). 2009;88:193–
201.
5. Cronin CG, Lohan DG, Blake MA, Roche C,
McCarthy P, Murphy JM. Retroperitoneal fibrosis:
a review of clinical features and imaging findings.
AJR Am J Roentgenol. 2008;191:423–31.
6. Demko TM, Diamond JR, Groff J. Obstructive
nephropathy as a result of retroperitoneal fibrosis:
a review of its pathogenesis and associations. J Am
Soc Nephrol. 1997; 8:684-8.
7. Vaglio A, Palmisano A, Alberici F, et al. Prednisone
versus tamoxifen in patients with idiopathic
retroperitoneal fibrosis: an open-label randomised
controlled trial. Lancet 2011; 378:338-46.
8. Moroni G, Castellani M, Balzani A, et al. The value
of (18)F-FDG PET/CT in the assessment of active
idiopathic retroperitoneal fibrosis. Eur J Nucl Med
Mol Imaging. 2012;39:1635-42.
Giordano A. Usefulness of whole-body fluorine-18-
fluorodeoxyglucose positron emission tomography
in patients with large-vessel vasculitis: a systematic
review. Clin Rheumatol. 2011;30:1265-75.
2. Tahara N, Imaizumi T, Virmani R, Narula
J.Clinicalfeasibilityofmolecular
imagingofplaqueinflammation in atherosclerosis. J
Nucl Med. 2009;50:331-4.
3. Nakajo M, Jinnouchi S, Tanabe H, Tateno R, Nakajo
M. 18F-fluorodeoxyglucose positron emission
tomography features of idiopathic retroperitoneal
fibrosis. J Comput Assist Tomogr. 2007;31:539-43.
4. van Bommel EF, Jansen I, Hendriksz TR, Aarnoudse
AL. Idiopathic retroperitonealfibrosis: prospective
evaluation of incidence and clinicoradiologic
presentation.Medicine (Baltimore). 2009;88:193–
201.
5. Cronin CG, Lohan DG, Blake MA, Roche C,
McCarthy P, Murphy JM. Retroperitoneal fibrosis:
a review of clinical features and imaging findings.
AJR Am J Roentgenol. 2008;191:423–31.
6. Demko TM, Diamond JR, Groff J. Obstructive
nephropathy as a result of retroperitoneal fibrosis:
a review of its pathogenesis and associations. J Am
Soc Nephrol. 1997; 8:684-8.
7. Vaglio A, Palmisano A, Alberici F, et al. Prednisone
versus tamoxifen in patients with idiopathic
retroperitoneal fibrosis: an open-label randomised
controlled trial. Lancet 2011; 378:338-46.
8. Moroni G, Castellani M, Balzani A, et al. The value
of (18)F-FDG PET/CT in the assessment of active
idiopathic retroperitoneal fibrosis. Eur J Nucl Med
Mol Imaging. 2012;39:1635-42.
Downloads
Published
2018-02-07
How to Cite
DemirbaÅŸ, Åžeref, Aykan, M. B., Arslan, E., SaÄŸlam, K., & Okuyucu, K. (2018). A Case Of Retroperitoneal Fibrosis As A Confusing Reason Of Positive FDG/PET: Role Of FDG/PET In Retroperitoneal Fibrosis. National Journal of Integrated Research in Medicine, 7(2), 123–125. https://doi.org/10.70284/njirm.v7i2.1375
Issue
Section
Case Report
